Adalimumab-induced lichenoid drug eruption
LMJ-Lebanese Medical Journal. 2014; 62 (4): 238-240
in English
| IMEMR
| ID: emr-153677
ABSTRACT
Tumor necrosis factor [TNF]- alpha inhibitors are being widely and increasingly used for the management of a spectrum of rheumatologic diseases that are refractory to conventional disease modifying anti-rheumatic drugs. Various cutaneous side effects have been reported after treatment with TNF- alpha inhibitors. We present a case report of a 26-year- old male patient who developed a lichenoid drug eruption few months after the initiation of adalimumab for the manage- ment of Crohn's disease. We also highlight the clinical and histopathologic differences between lichenoid drug eruptions and idiopathic lichen planus
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Crohn Disease
/
Tumor Necrosis Factor-alpha
/
Drug Eruptions
/
Antibodies, Monoclonal, Humanized
Type of study:
Case report
Limits:
Humans
/
Male
Language:
English
Journal:
Lebanese Med. J.
Year:
2014
Similar
MEDLINE
...
LILACS
LIS